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Introduction
Recent small subcortical infarcts (RSSIs), for-
merly termed ‘lacunar strokes’ account for 
approximately 25% of all ischemic strokes.1,2 
They occur in the supplying area of a single, deep 
perforating brain artery and are mostly felt to be a 
consequence of cerebral small-vessel disease 
(CSVD).1 However, previous reports have sug-
gested that up to 15% of RSSIs may be caused 
rather by embolism or macroangiopathy [e.g. 
atrial fibrillation (AF) or ipsilateral carotid steno-
sis], especially in the absence of additional mag-
netic resonance imaging (MRI) signs of CSVD 
such as white matter hyperintensities (WMHs), 
lacunes or cerebral microbleeds.1,3–6
It has also been suggested that certain infarct 
characteristics, such as a larger size or a tubular/
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Abstract
Background: Recent small subcortical infarcts (RSSIs) mostly result from the occlusion of a 
single, small, brain artery due to intrinsic cerebral small-vessel disease (CSVD). Some RSSIs 
may be attributable to other causes such as cardiac embolism or large-artery disease, and 
their association with coexisting CSVD and vascular risk factors may vary with morphological 
magnetic resonance imaging (MRI) features.
Methods: We retrospectively identified all inpatients with a single symptomatic MRI-confirmed 
RSSI between 2008 and 2013. RSSIs were rated for size, shape, location (i.e. anterior: basal 
ganglia and centrum semiovale posterior cerebral circulation: thalamus and pons) and MRI 
signs of concomitant CSVD. In a further step, clinical data, including detailed diagnostic 
workup and vascular risk factors, were analyzed with regard to RSSI features.
Results: Among 335 RSSI patients (mean age 71.1 ± 12.1 years), 131 (39%) RSSIs were >15 mm 
in axial diameter and 66 (20%) were tubular shaped. Atrial fibrillation (AF) was present in 44 
(13.1%) and an ipsilateral vessel stenosis > 50% in 30 (9%) patients. Arterial hypertension and 
CSVD MRI markers were more frequent in patients with anterior-circulation RSSIs, whereas 
diabetes was more prevalent in posterior-circulation RSSIs. Larger RSSIs occurred more 
frequently in the basal ganglia and pons, and the latter were associated with signs of large-
artery atherosclerosis. Patients with concomitant AF had no specific MRI profile.
Conclusion: Our findings suggest the contribution of different pathophysiological mechanisms 
to the occurrence of RSSIs in the anterior and posterior cerebral circulation. While there 
appears to be some general association of larger infarcts in the pons with large-artery 
disease, we found no pattern suggestive of AF in RSSIs.
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cuneiform shape, might be associated with large-
artery disease, embolic occlusion or a more proxi-
mal occlusion of an arteriole.5,7–10 These 
considerations are in line with an ongoing discus-
sion about two different types of lacunar infarc-
tion; on the one hand, those RSSIs caused by an 
atheroma in the proximal portion of the perforat-
ing arteriole or parent artery, a pathology more 
suggestive of an atherosclerotic cause, and on the 
other hand, those attributable to lipohyalino-
sis.2,4,11 Furthermore, the association of RSSIs 
with vascular risk factors and concomitant cere-
brovascular changes may vary between different 
vascular perfusion territories. Lesion features that 
identified risk factors would be clinically useful to 
target the diagnostic workup and consequently, 
secondary stroke prevention.
To further explore these aspects, we investigated 
a consecutively collected series of patients who 
had presented with acute stroke related to a single 
RSSI on MRI.12 We specifically looked at associ-
ations between different RSSI characteristics 
(such as size and configuration) and specific risk-
factor profiles or evidence for possible infarct eti-
ology other than CSVD. We explored different 
areas of the brain separately, in case there were 
differences between the anterior and posterior 
cerebral circulation.
Methods
We retrospectively searched the medical docu-
mentation system of our primary and tertiary 
care university hospital for inpatients diagnosed 
with ‘acute ischemic stroke’ (ICD-10 code I63) 
from 1 January 2008 to 5 February 2013. Of 
4118 identified patients, 3363 had undergone 
brain MRI within 10 days from symptom onset 
[this time interval served to assure that acute 
infarcts were reliably captured by diffusion-
weighted imaging (DWI)].13 MRI scans were 
reviewed for the presence of RSSIs by two neu-
roimaging experts without any clinical informa-
tion and RSSIs were defined according to the 
STandards for ReportIng Vascular changes on 
nEuroimaging (STRIVE) criteria14 by: (a) pres-
ence of a hyperintense DWI lesion with corre-
sponding reduced diffusivity on the apparent 
diffusion coefficient (ADC) map compatible 
with acute ischemic infarction; (b) subcortical 
lesion location in four prespecified regions (basal 
ganglia including internal capsule, thalamus, 
centrum semiovale, and pons), suggestive of the 
supply area of a penetrating artery; and (c) a 
maximal axial lesion diameter of ⩽20 mm.6 
Patients were excluded if their scans showed 
multiple acute subcortical infarcts, additional 
acute infarcts in other locations, or other acute 
intracranial lesions (e.g. brain hemorrhage, 
tumor).12
MRI protocol and analysis
MRI of the brain was performed on 1.5 T scan-
ners (Siemens Symphony, Siemens, Erlangen, 
Germany; Philips Intera and Gyroscan ACS, 
Philips, Eindhoven, the Netherlands) according 
to a standard protocol for the workup of patients 
with suspected cerebrovascular events. This 
included an axial T2-weighted fast-spin-echo 
sequence, an axial T2-weighted fluid-attenuated 
inversion-recovery (FLAIR) sequence, a sagittal 
T1-weighted spin-echo sequence, a gradient-
echo T2*-weighted sequence, and an axial diffu-
sion-weighted single-shot echo planar-imaging 
sequence with ADC maps. All axial scans had a 
slice thickness of 5 mm.
We recorded the location of the RSSI according 
to four prespecified regions and the infarct shape 
was defined as either round/ovoid or tubular 
(Figures 1 and 2). We also looked for additional 
signs of CSVD, including WMHs, which were 
rated according to the Fazekas scale,13 micro-
bleeds and lacunes of presumed vascular origin, 
as defined by the STRIVE criteria.14 The pres-
ence of old cortical or cerebellar infarctions and 
of old hemorrhages was noted as well.
Clinical data
Demographic and clinical data including the 
past medical history, cardiovascular risk factors, 
as well as the National Institutes of Health 
Stroke Scale (NIHSS) score at admission and 
discharge were extracted from the electronic 
medical documentation system of our hospital. 
Risk factors were defined as arterial hyperten-
sion (pre-existing diagnosis or blood pressure ⩾ 
140/90 mmHg), hypercholesterolemia (pre-
existing diagnosis or fasting total cholesterol ⩾ 
200 mg/dl), diabetes mellitus [pre-existing diag-
nosis or glycated hemoglobin (HbA1c) defined 
by the International Federation of Clinical 
Chemistry as >42 mmol/mol], smoking, renal 
insufficiency [glomerular filtration rate (GFR) < 
60 ml/min/1.7 m²], coronary heart disease (CHD; 
S Eppinger, T Gattringer et al.
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pre-existing diagnosis or diagnosis during hos-
pitalization), peripheral arterial disease (PAD; 
pre-existing diagnosis or diagnosis during hos-
pitalization). We also extracted the results of 
12-lead electrocardiograms (ECGs) and neuro-
sonographic examinations of the extra- and 
intracranial brain-supplying vessels which were 
available on all patients, and recorded the infor-
mation from 24 h ECG and echocardiography, 
where available.
Statistical analysis
The Statistical Package for the Social Sciences (ver-
sion 21.0; SPSS Inc., Chicago, IL, USA) was used 
for data analysis. Dichotomous variables were ana-
lyzed using the Chi-square test. The Mann–Whitney 
U test and Kruskal–Wallis test were used for con-
tinuous nonparametric variables. Statistical signifi-
cance was accepted at p ⩽ 0.05. Analyses included 
a comparison of RSSI patients with (early confluent 
or confluent WMH, cerebral microbleeds, lacunes) 
Figure 1. RSSIs in the observed anatomical locations on DWI and FLAIR sequences (upper and lower rows, 
respectively).
(a) Thalamus; (b) internal capsule; (c) pons; (d) centrum semiovale.
DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery; RSSIs, recent small subcortical infarcts.
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versus those without other signs of CSVD. For the 
latter category, we only accepted the presence of 
punctate (grade 1) WMH. A comparison was also 
made between patients with RSSIs in the anterior 
(i.e. basal ganglia including internal capsule, cen-
trum semiovale) and in the posterior (i.e. thalamus, 
pons) cerebral circulation.
The study was approved by the ethics committee of 
the Medical University of Graz (25-409 ex 12/13).
Results
We identified 335 RSSI patients with a mean age 
of 71.1 (±12.1) years and 65% were men. The 
majority of RSSIs were located in the basal gan-
glia (n = 108) followed by pons (n = 90), thala-
mus (n = 76) and centrum semiovale (n = 61). A 
total of 131 (39%) RSSIs were >15 mm in axial 
diameter and 66 (20%) were tubular shaped. 
Moderate-to-severe WMHs (Fazekas grades 2 or 
3) were present in 190 (56.7%) patients, lacunes 
Figure 2. Example of a tubular RSSI in the basal ganglia depicted on DWI (upper half) and FLAIR (lower half).
DWI, diffusion-weighted imaging; FLAIR, fluid-attenuated inversion recovery; RSSI, recent small subcortical infarct.
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in 144 (43%) and microbleeds in 110 (32.8%). 
AF was found in 44 (13.1%) patients and an 
upstream > 50% vessel stenosis in 30 (9%) 
patients. Further characteristics regarding imag-
ing features as well as risk factors are shown in 
Table 1.
Patient and imaging characteristics according 
to RSSI location
Patient age and sex were not different according 
to RSSI location. Arterial hypertension was more 
prevalent in patients with anterior-circulation 
RSSIs in the basal ganglia or centrum semiovale, 
whereas diabetes was more common in patients 
with pontine or thalamic RSSIs (posterior circu-
lation). Other risk factors were equally frequent 
across different RSSI locations (Table 1).
Patients with RSSIs in the anterior circulation 
showed a significantly higher rate of concomitant 
CSVD signs such as WMH grades 2 or 3, lacunes 
and microbleeds (Table 1).
An upstream-vessel stenosis > 50% was detected 
primarily in patients with pontine RSSIs.
Stroke severity according to the NIHSS was more 
severe in patients with RSSIs in the basal ganglia 
and pons (Table 1).
Patient and imaging characteristics according 
to RSSI shape and size
There was no association between RSSI shape or 
size and patients’ age, but tubular-shaped RSSIs 
were more common in men (Table 2).
Round/ovoid RSSIs tended to be smaller than tubu-
lar RSSIs, and smaller RSSIs ⩽ 15 mm occurred 
more often in the centrum semiovale and thalamus, 
whereas larger lesions were more concentrated in 
the pons and basal ganglia (Table 2).
Diabetes mellitus was more prevalent in patients 
with round-/ovoid-shaped RSSIs and patients 
with upstream-vessel stenosis > 50% had larger 
RSSI diameters; otherwise, we found no differ-
ences in the distribution of risk factors according 
to RSSI shape or size (Table 2).
RSSI shape was not associated with stroke severity 
or outcome, while patients with an RSSI > 15 mm 
had higher NIHSS scores both at admission and 
at discharge and remained more often disabled 
than patients with an RSSI ⩽ 15 mm (Table 2).
Differences between RSSI patients with and 
without additional signs of CSVD
To also look at the impact of coexisting CSVD in 
a compound manner, we divided patients into 
those with no other morphologic abnormalities 
than at maximum punctate WMH according to 
Fazekas scale scores 0–1 (RSSI−) and those with 
additional signs of CSVD, that is, coexisting 
WMH Fazekas scale scores 2 or 3, microbleeds or 
lacunes (RSSI+). RSSI+ patients were signifi-
cantly older and had a higher prevalence of old 
infarcts involving the cortex or the cerebellum.
Smoking, diabetes mellitus, CHD and AF were 
equally distributed, whereas arterial hypertension 
and PAD occurred more often in RSSI+ patients 
(Table 3).
Anterior circulation RSSIs were associated with 
more (RSSI+), while posterior circulation RSSIs 
had less severe (RSSI−) accompanying chronic 
CSVD signs (Table 3).
Discussion
We extended previous work by analyzing a large 
series of consecutive patients in whom MRI had 
shown a single RSSI, irrespective of the results of 
the patients’ diagnostic workup.12 While arterial 
hypertension prevailed in patients with RSSI in 
the anterior cerebral circulation, diabetes mellitus 
was associated with infarcts in the posterior circu-
lation. Signs of concomitant CSVD were also 
associated to a greater extent with RSSI in the 
anterior circulation. We found no specific mor-
phologic RSSI features in patients who had AF, 
but proximal vessel stenosis was related to RSSI 
in the pons and a larger infarct size.
There is an ongoing discussion whether different 
RSSI imaging characteristics are associated with a 
distinct risk-factor profile. It has been argued that 
larger infarcts might be more likely in patients 
with an embolic source or branch atheromatous 
disease (BAD).5,9 For AF, we did not find any 
support for this assumption. Importantly the prev-
alence of AF was also similar in patients with and 
without coexisting chronic CSVD signs, which 
argues against a causative role. Proximal stenosis 
did show an association with larger infarcts but 
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Table 3. Comparison of patients with RSSI and different degrees of cerebral small-vessel disease.
All subjects  
(n = 335)
CSVD 
 No/mild 
CSVD (RSSI−) 
(n = 123)
Severe CSVD 
(RSSI+) (n = 212)
p
Characteristics:  
Age (±SD) 71.1 (±12.1) 67.25 (±13.1) 73.33 (±10.9) <0.0001
Male (%) 217 (64.8) 80 (65.0) 137 (64.6) n.s.
Round/ovoid shape (%) 269 (80.3) 95 (77.2) 174 (82.1) n.s.
Tubular shape (%) 66 (19.7) 28 (22.8) 38 (17.9) n.s.
⩽15 mm (%) 204 (60.9) 73 (59.3) 131 (61.8) n.s.
>15 mm (%) 131 (39.1) 50 (40.7) 81 (38.2) n.s.
Pons (%) 90 (26.9) 43 (35.0) 47 (22.2) 0.001
Thalamus (%) 76 (22.7) 36 (29.3) 40 (18.9)  
Basal ganglia (%) 108 (32.2) 31 (25.2) 77 (36.3)  
Centrum semiovale (%) 61 (18.2) 13 (10.6) 48 (22.6)  
Old cortical infarct (%) 59 (17.6) 11 (8.9) 48 (22.6) 0.002
Old cerebellar infarct (%) 31 (9.3) 2 (1.6) 29 (13.7) 0.0001
Smoking (%) 97 (28.9) 38 (30.9) 59 (28.0) n.s.
Arterial hypertension (%) 284 (84.8) 89 (72.4) 195 (92.0) <0.0001
Diabetes mellitus (%) 53 (15.8) 28 (22.8) 65 (30.7) n.s.
Hypercholesterolemia (%) 200 (59.7) 82 (66.7) 118 (55.7) 0.050
PAD (%) 26 (6.8) 4 (3.3) 22 (10.4) 0.019
CHD (%) 47 (14.0) 18 (14.6) 29 (13.7) n.s.
Atrial fibrillation (%) 44 (13.1) 13 (10.6) 31 (14.6) n.s.
Upstream-vessel stenosis > 50% (%) 30 (9) 13 (10.6) 17 (8) n.s.
Any-vessel stenosis > 50% (%) 63 (18.8) 23 (18.7) 40 (18.9) n.s.
Bold numerals denote statistical significance.
CHD, coronary heart disease; CSVD, cerebral small-vessel disease; n.s., nonsignificant; NIHSS, National Institutes of 
Health Stroke Scale; PAD, peripheral arterial disease; RSSI, recent small subcortical infarcts; SD, standard deviation.
not with tubular shaped lesions and this associa-
tion was largely driven by brainstem infarcts. 
Although there was an excess concurrence of ipsi-
lateral vessel stenosis among patients with lesions 
> 15 mm, notably, the impact of stenosis of the 
ipsilateral carotid artery has been disputed and is 
considered incidental rather than causative.15,16 
Our cohort did not differ substantially from others 
regarding carotid stenosis or embolic sources, 
such as AF; especially with regard to the latter, it 
was representative in mean age.17 Compared with 
the findings from two previous studies, we also 
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found no association between shape or size and 
AF;7,10 though larger, primarily pontine infarcts 
were associated with an upstream stenosis. One 
should also consider that different shape, as well 
as size, might reflect a highly individually dispa-
rate branching pattern of the perforating arteries, 
particularly in the basal ganglia.18
Our findings support the association of diabetes 
mellitus with lesions in the posterior circulation, 
especially in the brainstem.19–22 This might sug-
gest a higher vulnerability of the vertebrobasilar 
system to diabetic macro- and microangiopathy. 
The exact underlying mechanisms remain 
unknown to this day. A recent study addressing 
histopathological changes in the anterior and pos-
terior cerebral arteries revealed a higher predispo-
sition of the basilar artery to dilate, and vertebral 
arteries to be prone to concentric intima thicken-
ing and stenosis.23 Different embryological ori-
gins of the posterior and anterior circulation 
might be constitutive for those differences in the 
aging process of the vessels.23 Another important 
factor might be the concept of BAD, meaning an 
occlusion of the orifice of the branching perfora-
tion artery by a proximal atheroma or a luminal 
plaque in the parent artery. An autopsy study per-
formed in the 1970s showed a high frequency of 
diabetes mellitus associated with lesions in the 
posterior perfusion territory, especially in patients 
with an infarct pattern suggestive of BAD.20 
Recently, high-resolution (HR) and high-field 
MRI has enabled the detection of atheromatous 
plaques in the basilar artery, as well as the middle 
cerebral artery, potentially causing occlusions of 
perforators.5,24–26 Therefore, these sophisticated 
methods could be of particular interest in further 
investigations, specifically regarding the posterior 
circulation.
It was also interesting to note that old cortical or 
cerebellar infarcts were visible on MRI with 
a comparable frequency between patients with 
anterior versus posterior circulation RSSIs. 
However, other chronic features of CSVD were 
found preferentially in patients with RSSIs in the 
anterior circulation. This is consistent with a 
higher prevalence of hypertension in patients with 
RSSIs in the anterior circulation. The reason for 
a preponderance of CSVD in the anterior circula-
tion has not yet been determined, although other 
studies have noted it as well.19 As endothelial fail-
ure seems to play an important role in CSVD, dif-
ferences in the wall composition of arterioles and 
capillaries might be of specific interest. On the 
one hand, there is evidence for an age-related 
increase in endothelial permeability; on the other 
hand, vascular risk factors do seem to play an 
important role as well.4 Therefore, it is quite 
interesting that especially patients with infarcts in 
the centrum semiovale showed pronounced signs 
of CSVD in our study, as well as a high incidence 
of cardiovascular risk factors. In this brain region, 
there is an increased number of capillaries, the 
barrier function of the endothelium on the capil-
lary level is hypothesized to be more resistant 
than the arteriolar level.4 Our findings support 
these observations. Although not statistically sig-
nificant, those were also the oldest patients.
RSSI patients with severe CSVD signs were older 
than patients with no or only mild accompanying 
chronic cerebrovascular lesions. In general, 
WMHs tend to appear in the cerebral hemispheres 
before they occur in the brainstem area. There 
was no significant difference in age according to 
the location of the acute ischemic lesion. 
Nonetheless, it has to be considered that these 
observations might reflect different stages of 
CSVD. The question of whether occurrence of an 
isolated RSSI without concomitant signs of CSVD 
can be considered as a first sign of diffuse cerebral 
disease cannot be answered yet.4,27 Morphological 
characteristics of RSSIs did not allow prediction 
of future functional disability, except when it came 
to size and a location in the basal ganglia or pons, 
although this study did not follow up patients after 
discharge and cannot offer long-term functional 
prognoses. Like other studies, we also found that 
the larger the lesion, the worse the (at least short 
term) outcome.10,28 As the fibers are more tightly 
packed in subcortical regions, especially in the 
internal capsule and the brainstem, relatively small 
lesions are disconnecting a larger representative 
section of the cortex.29
We have to consider several limitations of our 
work. The selection of patients for our study was 
carried out based solely on imaging criteria accord-
ing to STRIVE, irrespective of the clinical stroke 
syndrome. As our study was conducted risk-factor 
free, inclusion of strokes of different etiologies 
might not have been entirely avoided. Most of the 
other studies of RSSI populations are subtyped or 
included by a risk-factor-based stroke classification 
system, thus, excluding patients with more severe 
vessel stenosis or a potential cardioembolic source. 
For our retrospective study, we used pre-existing 
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imaging material provided for diagnostics. These 
clinical standard images did not include coronal 
slices, making a definitive measurement of the lon-
gitudinal extent of a lesion difficult. Due to our 
study design, we could not provide a specific clini-
cal protocol. Thus, some examinations such as 
echocardiography and 24 h ECG were not per-
formed on every patient, potentially limiting the 
detection of cardiac-stroke causes in some patients. 
Notably, all patients received at least ECG and 
neurovascular sonography.
Further studies including and comparing RSSIs 
in the anterior- and posterior-perfusion territory 
with explicit attention to the presence of diabetes 
mellitus, as well as impaired glucose tolerance, 
could provide further crucial information. 
HR-MRI of relevant vessels could be meaningful 
for depicting subtle atheromatous changes, which 
may be causative of RSSIs. In the long term, it 
will be of interest whether those patients do show 
a different response to therapy or might even 
profit from a different treatment regime.
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